{"id":"https://openalex.org/W4400625136","doi":"https://doi.org/10.1016/s2352-3018(24)00130-9","title":"HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial","display_name":"HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial","publication_year":2024,"publication_date":"2024-07-13","ids":{"openalex":"https://openalex.org/W4400625136","doi":"https://doi.org/10.1016/s2352-3018(24)00130-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/39008999"},"language":"en","primary_location":{"id":"doi:10.1016/s2352-3018(24)00130-9","doi":"https://doi.org/10.1016/s2352-3018(24)00130-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3018(24)00130-9","pdf_url":null,"source":{"id":"https://openalex.org/S2531945440","display_name":"The Lancet HIV","issn_l":"2352-3018","issn":["2352-3018","2405-4704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet HIV","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17615/9sxk-cn79","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060710888","display_name":"David Alain Wohl","orcid":"https://orcid.org/0000-0002-7764-0212","observed_orcids":["https://orcid.org/0000-0002-7764-0212"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Wohl","raw_affiliation_strings":["Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045808037","display_name":"Christoph D. Spinner","orcid":"https://orcid.org/0000-0002-3875-5367","observed_orcids":["https://orcid.org/0000-0002-3875-5367"]},"institutions":[{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph D Spinner","raw_affiliation_strings":["TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TUM School of Medicine and Health, Department of Clinical Medicine - Clinical Department for Internal Medicine II, University Medical Centre, Technical University of Munich, Munich, Germany","institution_ids":["https://openalex.org/I62916508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058608689","display_name":"Jason Flamm","orcid":"https://orcid.org/0009-0001-2057-4218","observed_orcids":["https://orcid.org/0009-0001-2057-4218"]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4210122132","display_name":"Kaiser Permanente Sacramento Medical Center","ror":"https://ror.org/02q404g62","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210122132"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Flamm","raw_affiliation_strings":["Kaiser Permanente, Sacramento, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente, Sacramento, CA, USA","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210122132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103555189","display_name":"Charles Bradley Hare","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I4210122929","display_name":"Kaiser Permanente San Francisco Medical Center","ror":"https://ror.org/02fxsj090","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210122929"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Bradley Hare","raw_affiliation_strings":["Kaiser Permanente, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kaiser Permanente, San Francisco, CA, USA","institution_ids":["https://openalex.org/I1343052199","https://openalex.org/I4210122929"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019635523","display_name":"Susanne Doblecki\u2010Lewis","orcid":"https://orcid.org/0000-0001-6535-6698","observed_orcids":["https://orcid.org/0000-0001-6535-6698"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne Doblecki-Lewis","raw_affiliation_strings":["Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089993955","display_name":"Peter Jerome Ruane","orcid":"https://orcid.org/0000-0002-7170-9928","observed_orcids":["https://orcid.org/0000-0002-7170-9928"]},"institutions":[{"id":"https://openalex.org/I4210148755","display_name":"Ruane Medical","ror":"https://ror.org/05prbcv50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148755"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter J Ruane","raw_affiliation_strings":["Ruane Clinical Research, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ruane Clinical Research, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210148755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046238828","display_name":"Jean\u2010Michel Molina","orcid":"https://orcid.org/0000-0001-8684-2214","observed_orcids":["https://orcid.org/0000-0001-8684-2214","https://orcid.org/0000-0002-6711-8754"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210086835","display_name":"G\u00e9nomes, biologie cellulaire et th\u00e9rapeutiques","ror":"https://ror.org/002fxfq97","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I187986737","https://openalex.org/I204730241","https://openalex.org/I4210086835","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210119095","display_name":"H\u00f4pital Lariboisi\u00e8re","ror":"https://ror.org/02mqtne57","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210119095"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Michel Molina","raw_affiliation_strings":["Infectious Diseases Department, Hopitaux Saint-Louis Lariboisi\u00e8re, University of Paris and INSERM U944, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Department, Hopitaux Saint-Louis Lariboisi\u00e8re, University of Paris and INSERM U944, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210086835","https://openalex.org/I4210119095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073100933","display_name":"Anthony Mills","orcid":"https://orcid.org/0000-0002-6997-5581","observed_orcids":["https://orcid.org/0000-0002-6997-5581"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Mills","raw_affiliation_strings":["Men's Health Foundation, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Men's Health Foundation, Los Angeles, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110434587","display_name":"Cynthia C Brinson","orcid":"https://orcid.org/0000-0002-3024-2815","observed_orcids":["https://orcid.org/0000-0002-3024-2815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia Brinson","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069170911","display_name":"Moti N. Ramgopal","orcid":"https://orcid.org/0000-0001-7448-1976","observed_orcids":["https://orcid.org/0000-0001-7448-1976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moti Ramgopal","raw_affiliation_strings":["Midway Research Center, Fort Pierce, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midway Research Center, Fort Pierce, FL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035679710","display_name":"Amanda E. Clarke","orcid":"https://orcid.org/0000-0002-4632-2035","observed_orcids":["https://orcid.org/0000-0002-4632-2035","https://orcid.org/0000-0001-5701-7733"]},"institutions":[{"id":"https://openalex.org/I2800342113","display_name":"Royal Sussex County Hospital","ror":"https://ror.org/05fe2n505","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800342113","https://openalex.org/I4210151332"]},{"id":"https://openalex.org/I4210151332","display_name":"University Hospitals Sussex NHS Foundation Trust","ror":"https://ror.org/03wvsyq85","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210151332"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amanda Clarke","raw_affiliation_strings":["Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, UK","institution_ids":["https://openalex.org/I2800342113","https://openalex.org/I4210151332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091909943","display_name":"Gordon E. Crofoot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon Crofoot","raw_affiliation_strings":["The Crofoot Research Centre, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Crofoot Research Centre, Houston, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003323389","display_name":"Claudia T. Martorell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia Martorell","raw_affiliation_strings":["The Research Institute, Springfield, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Research Institute, Springfield, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073519594","display_name":"Christoph C Carter","orcid":"https://orcid.org/0000-0001-7793-8011","observed_orcids":["https://orcid.org/0000-0001-7793-8011"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christoph Carter","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA. Electronic address: christoph.carter7@gilead.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA. Electronic address: christoph.carter7@gilead.com","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephanie Cox","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Cox","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019270361","display_name":"J. Carlo Hojilla","orcid":"https://orcid.org/0000-0001-8654-8445","observed_orcids":["https://orcid.org/0000-0001-8654-8445"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Carlo Hojilla","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003994482","display_name":"Yongwu Shao","orcid":"https://orcid.org/0009-0009-5384-5131","observed_orcids":["https://orcid.org/0009-0009-5384-5131"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongwu Shao","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076529428","display_name":"Moupali Das","orcid":"https://orcid.org/0000-0001-5034-8185","observed_orcids":["https://orcid.org/0000-0001-5034-8185"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moupali Das","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029247334","display_name":"Alexander Kintu","orcid":"https://orcid.org/0000-0003-3957-1487","observed_orcids":["https://orcid.org/0000-0003-3957-1487"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Kintu","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064486492","display_name":"Jared M. Baeten","orcid":"https://orcid.org/0000-0001-8242-8438","observed_orcids":["https://orcid.org/0000-0001-8242-8438"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jared M Baeten","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029871990","display_name":"Robert M. Grant","orcid":"https://orcid.org/0000-0002-0851-7085","observed_orcids":["https://orcid.org/0000-0002-0851-7085"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I2800736834","display_name":"San Francisco AIDS Foundation","ror":"https://ror.org/04abvbp84","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800736834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M Grant","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA; San Francisco AIDS Foundation, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I2800736834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013318234","display_name":"Karam Mounzer","orcid":"https://orcid.org/0000-0001-8537-7103","observed_orcids":["https://orcid.org/0000-0001-8537-7103"]},"institutions":[{"id":"https://openalex.org/I860670893","display_name":"Philadelphia Fight","ror":"https://ror.org/00np1gf38","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I860670893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karam Mounzer","raw_affiliation_strings":["Philadelphia FIGHT Community Health Centres, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philadelphia FIGHT Community Health Centres, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I860670893"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025150770","display_name":"Kenneth Hugh Mayer","orcid":"https://orcid.org/0000-0001-7460-733X","observed_orcids":["https://orcid.org/0000-0001-7460-733X","https://orcid.org/0000-0001-8034-5110"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I44580034","display_name":"Fenway Health","ror":"https://ror.org/04ztdzs79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I44580034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Mayer","raw_affiliation_strings":["The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Centre/Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I44580034"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":19,"corresponding_author_ids":["https://openalex.org/A5073519594"],"corresponding_institution_ids":["https://openalex.org/I4210140816"],"apc_list":{"value":6300,"currency":"USD","value_usd":6300},"apc_paid":null,"fwci":2.4048,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.88573218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"11","issue":"8","first_page":"e508","last_page":"e521"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.17810000479221344,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.8489999771118164},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hiv-1-drug-resistance","display_name":"HIV-1 drug resistance","score":0.75},{"id":"https://openalex.org/keywords/genotype-resistance","display_name":"genotype resistance","score":0.8080000281333923},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.5590000152587891},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.6729999780654907},{"id":"https://openalex.org/keywords/tenofovir-diphosphate","display_name":"tenofovir diphosphate","score":0.6669999957084656},{"id":"https://openalex.org/keywords/hiv-incidence","display_name":"HIV incidence","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.9318139553070068},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.926948070526123},{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.9028657674789429},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6066315770149231},{"id":"https://openalex.org/C2779496540","wikidata":"https://www.wikidata.org/wiki/Q7239230","display_name":"Pre-exposure prophylaxis","level":5,"score":0.5764966011047363},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.55727618932724},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.43905457854270935},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.43388450145721436},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.43335938453674316},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.42992857098579407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37156230211257935},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35997939109802246},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30068260431289673},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.25660961866378784},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2091396450996399},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.14692220091819763},{"id":"https://openalex.org/C2776939746","wikidata":"https://www.wikidata.org/wiki/Q853451","display_name":"Men who have sex with men","level":4,"score":0.09741950035095215},{"id":"https://openalex.org/C2776983459","wikidata":"https://www.wikidata.org/wiki/Q41083","display_name":"Syphilis","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065129","descriptor_name":"Pre-Exposure Prophylaxis","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/s2352-3018(24)00130-9","doi":"https://doi.org/10.1016/s2352-3018(24)00130-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2352-3018(24)00130-9","pdf_url":null,"source":{"id":"https://openalex.org/S2531945440","display_name":"The Lancet HIV","issn_l":"2352-3018","issn":["2352-3018","2405-4704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet HIV","raw_type":"journal-article"},{"id":"pmid:39008999","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39008999","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The lancet. HIV","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:cdr.lib.unc.edu:5x21tw53x","doi":null,"is_oa":true,"landing_page_url":"https://cdr.lib.unc.edu/downloads/4m90f8979","pdf_url":"https://doi.org/10.17615/9sxk-cn79","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Lancet HIV, 11(8)","raw_type":"Article"},{"id":"pmh:oai:mediatum.ub.tum.de:node/1796440","doi":null,"is_oa":false,"landing_page_url":"https://mediatum.ub.tum.de/1796440","pdf_url":null,"source":{"id":"https://openalex.org/S4306400453","display_name":"mediaTUM \u2013 the media and publications repository of the Technical University Munich (Technical University Munich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I62916508","host_organization_name":"Technical University of Munich","host_organization_lineage":["https://openalex.org/I62916508"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"doi:10.17615/9sxk-cn79","doi":"https://doi.org/10.17615/9sxk-cn79","is_oa":true,"landing_page_url":"https://doi.org/10.17615/9sxk-cn79","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:cdr.lib.unc.edu:5x21tw53x","doi":null,"is_oa":true,"landing_page_url":"https://cdr.lib.unc.edu/downloads/4m90f8979","pdf_url":"https://doi.org/10.17615/9sxk-cn79","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Lancet HIV, 11(8)","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G9000894295","display_name":"The University of North Carolina Center for AIDS Research","funder_award_id":"P30AI050410","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312382","display_name":"ViiV Healthcare","ror":"https://ror.org/01cc9yk21"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320323316","display_name":"Shionogi","ror":"https://ror.org/01v3bqg10"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400625136.pdf","grobid_xml":"https://content.openalex.org/works/W4400625136.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1925000895","https://openalex.org/W1977229201","https://openalex.org/W2082146526","https://openalex.org/W2103920597","https://openalex.org/W2113255660","https://openalex.org/W2132977017","https://openalex.org/W2138391170","https://openalex.org/W2171609071","https://openalex.org/W2580221178","https://openalex.org/W2600111712","https://openalex.org/W2602409846","https://openalex.org/W2725415252","https://openalex.org/W2754765066","https://openalex.org/W2784305126","https://openalex.org/W2789678217","https://openalex.org/W2804196938","https://openalex.org/W2899917447","https://openalex.org/W2928530166","https://openalex.org/W3013272485","https://openalex.org/W3013666654","https://openalex.org/W3045256412","https://openalex.org/W3175868284","https://openalex.org/W3183487031","https://openalex.org/W3190424399","https://openalex.org/W4224248546","https://openalex.org/W4226116413","https://openalex.org/W4229012193","https://openalex.org/W4292492988","https://openalex.org/W4310567938","https://openalex.org/W4386593313"],"related_works":["https://openalex.org/W3175868284","https://openalex.org/W4400619303","https://openalex.org/W3172555725","https://openalex.org/W3045256412","https://openalex.org/W2134966461","https://openalex.org/W2301510887","https://openalex.org/W3164547666","https://openalex.org/W4392785398","https://openalex.org/W2031314524","https://openalex.org/W2903077777"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-07-15T00:00:00"}